Today, Research Analysts’ Updated EPS Estimates for November, 28th (ALB, BABY, BGG, BLRX, BR, CBT, CGIX, COTQF, CPK, CS)

Today, Research Analysts’ Updated EPS Estimates for November, 28th (ALB, BABY, BGG, BLRX, BR, CBT, CGIX, COTQF, CPK, CS)

Research Analysts’ updated eps estimates for Monday, November 28th:

Albemarle Corp. (NYSE:ALB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $94.00 price target on the stock. According to Zacks, “Albemarle Corporation is a major producer of fine and performance chemicals including polymer intermediates, cleaning product intermediates and additives, agricultural chemical intermediates, pharmaceutical intermediates, catalysts, brominated flame retardants, bromine chemicals and potassium and chlorine chemicals. “

Natus Medical (NASDAQ:BABY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. “

Briggs & Stratton Corp. (NYSE:BGG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $24.00 target price on the stock. According to Zacks, “Briggs & Stratton Corp. is one of the world’s largest producers of air cooled gasoline engines for outdoor power equipment. The company designs, manufactures, markets and services these products for original equipment manufacturers worldwide. These engines are primarily aluminum alloy gasoline engines. “

BioLineRx (NASDAQ:BLRX) had its buy rating reissued by analysts at Roth Capital. They currently have a $7.00 target price on the stock.

Broadridge Financial Solutions (NYSE:BR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Broadridge is a leading global provider of technology-based outsourcing solutions to the financial services industry. Their integrated systems and services include investor communication, securities processing, and clearing and outsourcing solutions. Broadridge offers a broad, integrated suite of innovative global solutions across the investment lifecycle and provides a wide range of cost-effective and scalable solutions to the financial industry. Their systems help reduce the need for clients to make significant capital investments in operations infrastructure, thereby allowing them to increase their focus on core business activities. “

Cabot Corp. (NYSE:CBT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Cabot Corporation is a global specialty chemicals and materials company. Cabot’s major products are carbon black, fumed silica, inkjet colorants, and aerogels. Cabot has manufacturing plants located in countries around the world. (Company Press Release) “

Cancer Genetics (NASDAQ:CGIX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company’s tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey. “

Critical Outcome T Com Npv (NASDAQ:COTQF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Critical Outcome Technologies Inc. is a biopharmaceutical company which focuses on treatment of cancer. The company’s product consists of COTI-2, a novel p53-dependent mechanism of action with selective and potent anti-cancer activity. Its artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds from disease specific drug discovery through chemical optimization and preclinical testing. Critical Outcome Technologies Inc. is based in London, Canada. “

Chesapeake Utilities Corp. (NYSE:CPK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Chesapeake Utilities Corporation is a utility company engaged in natural gas distribution and transmission, propane distribution and marketing, advanced information services and other related businesses.Chesapeake’s three natural gas distribution divisions serve residential, commercial and industrial customers in southern Delaware, Maryland’s Eastern Shore and Florida. The Company’s natural gas transmission subsidiary operates an interstate pipeline system that transports gas from various points in Pennsylvania to Delaware and Maryland distribution divisions. “

Credit Suisse Group AG (NYSE:CS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CREDIT SUISSE GROUP and Winterthur offer investment products, private banking and financial advisory services, as well as insurance and pension solutions. Credit Suisse First Boston provides securities underwriting, sales and trading, financial advisory, investment research, venture capital and asset management services. Because they specialize in gaining a deep understanding of their clients’ financial needs, they know that no one’s needs are two-dimensional. 360° Choice. “

Casella Waste Systems (NASDAQ:CWST) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Casella Waste Systems, Inc. is a regional, integrated solid waste services company that provides collection, transfer, disposal and recycling services, generates steam and manufactures finished products utilizing recyclable materials primarily throughout the eastern portion of the United States and parts of Canada. The Company also markets recyclable metals, aluminum, plastics, paper and corrugated cardboard all processed at its facilities and recyclables purchased from third parties. “

Daktronics (NASDAQ:DAKT) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $12.00 target price on the stock. According to Zacks, “Daktronics Inc. has strong leadership positions in, and is one of the world’s largest suppliers of, electronic scoreboards, computer-programmable displays, and large screen video displays and control systems. The company excels in the control of large display systems, including those that require integration
of multiple complex displays showing real-time information, graphics, animation and video. Daktronics designs, manufactures, markets and services display systems for customers around the world in sport, business and transportation applications. “

Danone SA (NASDAQ:DANOY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Danone SA is engaged in food processing activities primarily in France and internationally. The Company operates in four business lines: Fresh Dairy Products, Waters, Baby Nutrition, and Medical Nutrition. The Fresh Dairy Products division produces and markets yogurts, fermented fresh dairy products, and other specialized fresh dairy products .The Waters division produces and distributes packaged natural, flavored, and vitamin-enriched water. The Baby Nutrition division provides food for infants and toddlers to complement breast-feeding. The Medical Nutrition division offers products to treat disease-related to malnutrition. Danone SA, formerly known as Groupe Danone, is based in Paris, France. “

Guess (NYSE:GES) had its buy rating reissued by analysts at Wunderlich. They currently have a $27.00 target price on the stock.

Goldman Sachs BDC (NYSE:GSBD) was downgraded by analysts at Goldman Sachs Group Inc. from a buy rating to a neutral rating.

Harley-Davidson (NYSE:HOG) had its overweight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $61.00 target price on the stock, up from their previous target price of $54.00.

Hanwha Q Cells Co. (NASDAQ:HQCL) had its neutral rating reissued by analysts at Roth Capital. Roth Capital currently has a $10.00 target price on the stock, down from their previous target price of $13.00.

Lion Biotechnologies (NASDAQ:LBIO) had its buy rating reiterated by analysts at Roth Capital. The firm currently has a $15.00 target price on the stock.

Mueller Water Products (NYSE:MWA) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $15.00 price target on the stock, up from their previous price target of $13.00.

Nutanix (NASDAQ:NTNX) had its neutral rating reissued by analysts at BTIG Research.

Palo Alto Networks (NYSE:PANW) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They currently have a $184.00 target price on the stock.

Prudential Financial Inflation-Linked Retail Medium Linked Retail Medium-Term Notes due April 10, 2018 (NYSE:PFK) had its market perform rating reaffirmed by analysts at FBR & Co. They currently have a $100.00 target price on the stock, up from their previous target price of $86.00.

Related posts

Leave a Comment